COSCIENS Biopharma Inc T.CSCI

Alternate Symbol(s): CSCI

Healthcare Biotechnology

COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.

TSX:CSCI - Post by User

COSCIENS Biopharma Inc > Email Response from Gilles Gagnon on March 12, 2024

<< Previous

Bullboard Posts

Next >>

Comment by scarface9on Nov 21, 2024 6:33pm

47 Views

Post# 36324945

RE:RE:Email Response from Gilles Gagnon on March 12, 2024

Hopeforthebest wrote: YEH, gagnon, that is why in the next while you will abondon the ship with a massive payout leaving nothing left.

You are failure on several magnitudes. You have ruin 3 companies and have failed to advance and product to completion after years and years of misstated timelines and pipeline. You are a failure as a business man (3 failed companies) and you are a failure as a scientist never once being able to develop a product to completion or on time.

This is what you are and will be remembered as. OINK, OINK, OINK

I wouldn't call him a failure. I'd say he's a successful conman.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing